-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Four years ago, the "Doctor Dingxiang" public account released "A year of 750 million brainwashing drugs, please let go of the Chinese elderly", bombarding Sharp Aisi eye drops for over-promotion of the product without obvious efficacy.
Three days after the article was published, the CFDA issued a document: In view of the fact that some doctors in the medical profession questioned the efficacy of benda lysine eye drops produced by Zhejiang Sharp Aisi Pharmaceutical Co.
The American Academy of Ophthalmology's 2016 "Clinical Guidelines for Adult Cataracts" stated: "For humans, there is currently no drug that can effectively treat or delay the progression of cataracts
The first hypothesis is that Shapuaisi eye drops have clear clinical evidence for the prevention and treatment of cataracts
The second hypothesis is that although Sharp Aisi Eye Drops currently has no clear clinical evidence for the prevention and treatment of cataracts, the company has full confidence in its claimed effects
From the above two assumptions, it can be inferred that the company still has no clear evidence of clinical effectiveness, nor does it have confidence in its declared efficacy
It is definitely impossible not to do clinical effectiveness trials.
The three-year period stipulated by the CFDA expired in December last year (2020.
Of course it’s not good to postpone, but you see that I have already started doing what you said, but I haven’t finished it yet
According to the 2021 semi-annual report of Sharp Ass, the consistency evaluation of bendal lysine eye drops was launched in 2016.
The new crown epidemic has not yet completely ended.
According to the official website of the State Food and Drug Administration, the approval date for re-registration of Sharp Aisi eye drops is December 2019.
Why was Sharp's eye drops being hammered four years ago? The medical profession recognizes that there is no medicine that can cure or prevent the development of cataracts.
Shap Aisi Eye Drops is just a small Boss in Novice Village, with low attack and low defense.
We have said so much today to say that Shap Aisi eye drops, no
Don't ask me what the "magic drugs" are called, the question is the "National Key Monitoring and Rational Use Drug List"
